NCT00408083View on ClinicalTrials.gov

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Peripheral Vascular Disease
Interventions
DRUG

MultiHance

0.5 mmol/kg as a single dose administration

DRUG

Magnevist

0.5 mmol/kg as a single dose administration

Trial Locations (1)

20134

Bracco Imaging, Milan

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY